Once- versus twice-daily abacavir and lamivudine in African children: the randomised controlled ARROW Trial

BACKGROUND: ART adherence is critical for successful HIV treatment outcomes. Once-daily dosing could improve adherence. Plasma concentrations of once- vs twice-daily abacavir+lamivudine are bioequivalent in children, but no randomised trial has compared virological outcomes. METHODS: Children taking...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:AIDS
Main Authors: Musiime, Victor, Kasirye, Philip, Naidoo-James, Bethany, Nahirya-Ntege, Patricia, Mhute, Tawanda, Cook, Adrian, Mugarura, Lincoln, Munjoma, Marshall, Thoofer, Navdeep K, Ndashimye, Emmanuel, Nankya, Immaculate, Spyer, Moira J., Thomason, Margaret J., Snowden, Wendy, Gibb, Diana M., Walker, A. Sarah
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6217915/
https://ncbi.nlm.nih.gov/pubmed/27064996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000001116
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados